NRAS and melanoma: In the current study, we screened seven human melanoma cells lines representing distinct oncogenic drivers (two BRAF wild type, five BRAF600E and one NRAS mutant) for their basal metabolic phenotype and observed that all of them displayed OCR/ECAR ratio indicative of OXPHOS activity.